You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

Litigation Details for Otsuka Pharmaceutical Co., Ltd. v. Lupin Limited (D. Del. 2021)

✉ Email this page to a colleague

« Back to Dashboard

Otsuka Pharmaceutical Co., Ltd. v. Lupin Limited (D. Del. 2021)

Docket	⤷ Sign Up	Date Filed	2021-06-23
Court	District Court, D. Delaware	Date Terminated	2024-08-07
Cause	35:271 Patent Infringement	Assigned To	Richard Gibson Andrews
Jury Demand	None	Referred To
Patents	8,501,730
Link to Docket	External link to docket

Small Molecule Drugs cited in Otsuka Pharmaceutical Co., Ltd. v. Lupin Limited

The small molecule drugs covered by the patent cited in this case are ⤷ Sign Up and ⤷ Sign Up .

Details for Otsuka Pharmaceutical Co., Ltd. v. Lupin Limited (D. Del. 2021)

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Date Filed	Document No.	Description	Snippet	Link To Document
0000-00-00				External link to document
2024-07-31	158	Opinion	U.S. Patent No. 8,501,730 (the “’730 patent”) and U.S. Patent No. 8,273,735 (the “’735 patent”). (See…Lupin infringed the ’730 patent and U.S. Patent No. 10,905,694 (“the ’694 patent”). (D.I. 1 ¶ 1). Otsuka… 569:1–21). The ’510 patent is a blocking patent to the ’735 patent. 36. In 1998…21–574:5). The ’677 patent is not a blocking patent to the ’735 patent. 37. The…treatment claims. The ’510 patent is a blocking patent while the ’677 patent is not. Otsuka submits	External link to document
2022-03-07	38	Patent/Trademark Report to Commissioner of Patents	the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,501,730 B2; 10,905,694 B2; …June 2021 7 August 2024 1:21-cv-00900 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
2021-06-23	4	Patent/Trademark Report to Commissioner of Patents	the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,501,730 ; 10,905,694. (smg)…June 2021 7 August 2024 1:21-cv-00900 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
2022-07-26	61	Opinion - Memorandum Opinion	terms in U.S. Patent Nos. 8,501,730 ("the '730 patent") and U.S. Patent No. 10,905,694…construction for multiple terms in U.S. Patent Nos. 8,501,730 and U.S. Patent No. 10,905,694. Signed by Judge …quot;It is a bedrock principle of patent law that the claims of a patent define the invention to which …construing patent claims, a court considers the literal language of the claim, the patent specification… A. The '730 Patent Claim 1 of the '730 patent is representative of the two	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.